Recent News

• 06.13.2025 - GT Biopharma Appoints New Member to its Board of Directors
• 06.11.2025 - S-1 - General form for registration of securities under the Securities Act of 1933
• 06.11.2025 - DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 06.11.2025 - DEF 14A - Definitive proxy statements
• 06.11.2025 - 8-K - Current report
• 06.03.2025 - 3 - Initial statement of beneficial ownership of securities
• 06.02.2025 - SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors
• 05.30.2025 - PRE 14A - Preliminary proxy statement not related to a contested matter or merger/acquisition
• 05.29.2025 - 3 - Initial statement of beneficial ownership of securities
• 05.28.2025 - D - Notice of Exempt Offering of Securities

Recent Filings

• 06.11.2025 - S-1 General form for registration of securities under the Securities Act of 1933
• 06.11.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 06.11.2025 - 8-K Current report
• 06.11.2025 - DEF 14A Other definitive proxy statements
• 06.03.2025 - 3 Initial statement of beneficial ownership of securities
• 06.02.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.30.2025 - PRE 14A Other preliminary proxy statements
• 05.29.2025 - 3 Initial statement of beneficial ownership of securities
• 05.28.2025 - D Notice of Exempt Offering of Securities